Czech urology, 2024 (vol. 28), issue 2

Editorial

MUDr. Igor Hartmann, Ph.D.

Ces Urol 2024, 28(2):65  

Minimally invasive robot assisted nephropexy

Milan Hora, Tomáš Ürge, Olga Dolejšová, Petr Stránský, Adriena Bartoš Veselá, Tomáš Pitra, Hana Sedláčková, Petr Stránský jr., Dominika Šiková

Ces Urol 2024, 28(2):66-68  

Hora M, Ürge T, Dolejšová O, Stránský P, Bartoš Veselá A, Pitra T, Sedláčková H, Stránský P jr, Šiková D. Minimally invasive robot assisted nephropexy. Objective: To present our contemporary technique of minimally invasive nephropexy. We follow data based on clinical studies of lower quality recommending the laparoscopic technique of suturing of a renal capsule at the convexity of kidney. Material, methods: Indications for surgery are symptomatic patients with proven nephroptosis on radiological examinations (mainly IVU). From 12/2004 until 4/2024, nephropexy was performed on 37 women. In 34 on the right side, two times on both sides and once on the...

Squamous cell carcinoma of penis - etiology, immune microenvironment and prognostic markers

Nicolette Zavillová, Jan Hrudka, Roman Zachoval

Ces Urol 2024, 28(2):69-88 | DOI: 10.48095/cccu2024012  

Zavillová N., Hrudka J., Zachoval R. Squamous cell carcinoma of penis - etiology, immune microenvironment and prognostic markers. Penile cancer is a relatively rare malignancy with a highly variable prognosis. The most important indicator of cancer specific survival (CSS) is the involvement of regional lymph nodes, which may not be identified during clinical examination or by conventional imaging methods. For that reason, new prognostic and therapeutic markers of penile squamous cell carcinoma (SCC) are currently being investigated at the histological, immunohistochemical and molecular level. Although the WHO classifies penile SCC into HPV-associated...

Qualitative and quantitative semen parameters in the light of the latest edition of the WHO manual for the examination and processing of human semen

Marcel Drlík, Zuzana Krátká, Jan Novák

Ces Urol 2024, 28(2):89-96 | DOI: 10.48095/cccu2024015  

Drlík M, Krátká Z, Novák J. Qualitative and quantitative semen parameters in the light of the latest edition of the WHO manual for the examination and processing of human semen. The assessment of fertility in a man is based on the semen examination. There isn't any single universal indicator, fertility is determined by a complex of quantitative and qualitative parameters. Methods for determining these parameters are evolving and becoming more precise. They are standardised in the WHO Manual, which is regularly updated. The latest is the sixth edition of 2021. The aim of this review article is to summarize the current options for male fertility testing...

Circulating tumor cells in oncourology

Alžběta Kantorová, Viktor Soukup, Otakar Čapoun

Ces Urol 2024, 28(2):97-104 | DOI: 10.48095/cccu2024016  

Kantorová A, Soukup V, Čapoun O. Circulating tumor cells in oncourology. In oncourology, we use a number of biomarkers for diagnosis, monitoring treatment, predicting relapse or resistance to therapy. The most commonly used biomarker in oncourology is prostate specific antigen (PSA) in the treatment of prostate cancer. Other markers used in testicular tumours are alpha-fetoprotein (AFP), beta-subunit of human chorionic gonadotropin (betahCG) and lactate dehydrogenase (LD). For bladder cancer we use urine cytology test, which despite good sensitivity and specificity in detecting high-grade urothelial carcinomas has the disadvantage of low sensitivity...

Prognostic significance of multiple transurethral resection in patients with T1 bladder cancer

Vladimír Košík, Michael Pešl, Monika Šlemendová, Alžběta Kantorová, Vojtěch Fiala, Otakar Čapoun, Viktor Soukup

Ces Urol 2024, 28(2):105-112 | DOI: 10.48095/cccu2024017  

Košík V, Pešl M, Šlemendová M, Kantorová A, Fiala V, Čapoun O, Soukup V. Prognostic significance of multiple transurethral resection in patients with T1 bladder cancer. Aim: The aim of this retrospective study is to investigate whether multiple transurethral resection (reTUR) in patients with T1 urothelial carcinoma of the bladder leads to worse prognosis and to evaluate the significance of individual prognostic factors in the first and second reTUR. Methods: A total of 363 patients diagnosed with T1 urothelial carcinoma between 2001 and 2022 were included in this retrospective study, of whom 260 patients underwent at least one reTUR and 103 patients...

Everolimus in treatment of bilateral giant angiomyolipomas

Kristýna Blažková, Vladimír Šámal, Igor Richter, Vít Paldus

Ces Urol 2024, 28(2):113-116 | DOI: 10.48095/cccu2024014  

Blažková K, Šámal V, Richter I, Paldus V. Everolimus in treatment of bilateral giant angiomyolipomas. The case study highlights the possibility of pharmacological therapy with everolimus for patients with extensive kidney angiomyolipomatosis, which poses a serious risk of bleeding to the patients.

Urachal adenocarcinoma in a young patient

Juraj Beniak, Kamil Belej, Marie Nováková, Miroslav Záleský

Ces Urol 2024, 28(2):117-120 | DOI: 10.48095/cccu2024011  

Beniak J, Belej K, Nováková M, Záleský M. Urachal adenocarcinoma in a young patient. We present a case of a young patient with a symptomatic urachal carcinoma. The patient underwent surgical resection at our department and is now in remission. Urachal cancer must be considered when examining a patient with visible hematuria.